|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/28 | (2015.01) |
| A61K 38/02 | (2013.01) | ||
| A61K 38/02 | (2006.01) | ||
| A61K 35/28 | (2013.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61P 37/02 | (2018.01) |
| (11) | Number of the document | 3478300 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17819499.9 |
| Date of filing the European patent application | 2017-06-29 | |
| (97) | Date of publication of the European application | 2019-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2017/050722 |
| Date | 2017-06-29 |
| (87) | Number | WO 2018/002930 |
| Date | 2018-01-04 |
| (30) | Number | Date | Country code |
| 201662356543 P | 2016-06-30 | US |
| (72) |
MAROM, Ehud , IL
BLEICH KIMELMAN, Nadav , IL
GRYNSPAN, Frida , IL
|
| (73) |
Stem Cell Medicine Ltd. ,
5 Kiryat Hamada Street, 91451 Jerusalem,
IL
Mapi Pharma Limited , 16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona, IL |
| (54) | TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH LONG ACTING GLATIRAMER AND ADIPOSE-DERIVED STEM CELLS |
| TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH LONG ACTING GLATIRAMER AND ADIPOSE-DERIVED STEM CELLS |